Business Context and Reporting Period
This Form 8-K Current Report was filed by TherapeuticsMD, Inc. on March 25, 2015. The filing addresses a change in the company's independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the administrative change of the external auditor.
Material Changes
- Dismissal of Prior Auditor: The Audit Committee voted to dismiss Rosenberg Rich Baker Berman & Company ("RRBB") as the independent registered public accounting firm.
- Engagement of New Auditor: Grant Thornton LLP ("GT") was engaged as the new independent registered public accounting firm for the 2015 fiscal year, effective March 30, 2015.
- Audit History: RRBB's reports for the fiscal years ended December 31, 2014, and December 31, 2013, contained no adverse opinions, disclaimers, or qualifications regarding uncertainty, audit scope, or accounting principles.
- Disagreements: There were no disagreements with RRBB on accounting principles, practices, or audit scope during the relevant periods.
- Consultations: No consultations occurred with GT regarding accounting principles or audit opinions prior to their engagement.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, or specific business risks. The primary disclosure relates to the procedural transition of the audit firm and the confirmation that no reportable events or disagreements existed during the tenure of the former auditor.
Investor Verification Checklist
- Verify the effective date of the new auditor (Grant Thornton LLP) is March 30, 2015.
- Confirm that the former auditor (RRBB) issued no adverse opinions for the 2013 and 2014 fiscal years.
- Review the attached letter from RRBB (Exhibit 16.1) to ensure they agree with the company's statements regarding the dismissal.
- Check subsequent filings for the first financial statements audited by Grant Thornton LLP.